Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
7.54
-0.05 (-0.66%)
At close: Nov 9, 2026
Coloplast Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 16,761 | 14,299 | 19,208 | 29,442 | 23,822 | 21,702 | |
Market Cap Growth | -20.49% | -25.56% | -34.76% | 23.59% | 9.77% | -34.94% |
Enterprise Value | 19,909 | 17,792 | 22,898 | 32,977 | 26,838 | 24,303 |
Last Close Price | 7.54 | 6.32 | 8.31 | 12.54 | 9.96 | 9.46 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 36.83 | 30.61 | 33.63 | 38.97 | 35.12 | 35.00 |
PS Ratio | 3.81 | 3.25 | 4.39 | 7.28 | 6.86 | 7.30 |
PB Ratio | 7.72 | 6.58 | 7.58 | 10.97 | 9.71 | 19.86 |
P/FCF Ratio | 16.66 | 14.21 | 22.90 | 123.04 | 52.39 | 39.48 |
P/OCF Ratio | 13.78 | 11.75 | 18.40 | 71.17 | 39.74 | 32.30 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
EV/Sales Ratio | 4.59 | 4.05 | 5.23 | 8.16 | 7.72 | 8.17 |
EV/EBITDA Ratio | 15.25 | 13.91 | 16.89 | 26.92 | 25.00 | 24.45 |
EV/EBIT Ratio | 17.84 | 15.72 | 18.88 | 30.17 | 27.63 | 26.66 |
EV/FCF Ratio | 19.79 | 17.69 | 27.30 | 137.81 | 59.02 | 44.21 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Debt / Equity Ratio | 1.51 | 1.51 | 1.40 | 1.26 | 1.13 | 2.26 |
Debt / EBITDA Ratio | 2.47 | 2.47 | 2.54 | 2.67 | 2.50 | 2.40 |
Debt / FCF Ratio | 3.25 | 3.25 | 4.24 | 14.14 | 6.10 | 4.48 |
Net Debt / Equity Ratio | 1.47 | 1.47 | 1.35 | 1.22 | 1.08 | 2.18 |
Net Debt / EBITDA Ratio | 2.50 | 2.50 | 2.51 | 2.67 | 2.47 | 2.40 |
Net Debt / FCF Ratio | 3.17 | 3.17 | 4.06 | 13.65 | 5.82 | 4.33 |
Asset Turnover | 0.61 | 0.61 | 0.58 | 0.56 | 0.57 | 0.85 |
Inventory Turnover | 2.43 | 2.43 | 2.35 | 2.44 | 2.44 | 2.51 |
Quick Ratio | 0.41 | 0.41 | 0.94 | 0.62 | 0.37 | 0.72 |
Current Ratio | 0.74 | 0.74 | 1.61 | 1.02 | 0.61 | 1.20 |
Return on Equity (ROE) | 20.21% | 20.21% | 21.35% | 28.67% | 37.38% | 57.18% |
Return on Assets (ROA) | 9.84% | 9.84% | 10.01% | 9.49% | 10.00% | 16.23% |
Return on Invested Capital (ROIC) | 16.60% | 16.27% | 11.75% | 15.25% | 17.45% | 29.00% |
Return on Capital Employed (ROCE) | 22.70% | 22.70% | 18.40% | 19.30% | 21.50% | 23.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Earnings Yield | 2.72% | 3.27% | 2.97% | 2.57% | 2.85% | 2.86% |
FCF Yield | 6.00% | 7.03% | 4.37% | 0.81% | 1.91% | 2.53% |
Dividend Yield | 4.60% | 5.51% | 4.24% | 2.52% | 2.81% | 2.58% |
Payout Ratio | 36.63% | 36.63% | 31.00% | 93.43% | 88.79% | 85.87% |
Buyback Yield / Dilution | - | - | -0.22% | -4.36% | -1.27% | 0.19% |
Total Shareholder Return | 4.60% | 5.51% | 4.02% | -1.85% | 1.54% | 2.77% |